# Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease

> **NCT06710574** · PHASE4 · RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Parkinson Disease
- Movement Disorders
- Rapid Eye Movement Sleep Behavior Disorder
- Gut Microbiomes
- Magnetic Resonance Imaging (MRI)
- Probiotic

## Interventions

- **DRUG:** PD-RBD
- **DRUG:** iRBD

## Key facts

- **NCT ID:** NCT06710574
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710574, "Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06710574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*